Tweaking Microtubules to Treat Scleroderma

Step 1: TGFβ binding to a type II receptor causes the receptor to recruit and phosphorylate a type I receptor. Step 2: phosphorylated type I receptor recruits and phosphorylates Smad2 or Smad3, upon which the Smads open up and expose a dimerization surface. Step 3: phosphorylated Smad2 or Smad3 dissociates from the receptor and oligomerizes with inhibitory Smad4. Step 4: the Smad2/3–Smad4 complex migrates to the nucleus, recruits other gene regulatory proteins (blue), and activates transcription of specific target genes.
Tweaking Microtubules to Treat Scleroderma

Publication

Tweaking Microtubules to Treat Scleroderma. (2005) Jacob M van Laar, et al. PLoS Med. 2005 Dec;2(12):e415. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates Smad2,3 SMAD2 ncbigene_symbol SMAD2 4087
Homo sapiens Primates Smad2,3 SMAD3 ncbigene_symbol SMAD3 4088
Homo sapiens Primates Step STEP ncbigene_synonym PTPN5 84867
Homo sapiens Primates Smad4 SMAD4 ncbigene_symbol SMAD4 4089

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID